Hepatoprotectors
- Active ingredient (INN)
- phospholipids
- Composition (active ingredients)
- phospholipids (in terms of phosphatidylcholine) - 50,0 mg
- Фармакотерапевтическая группа
- hepatoprotective agent
- Pharmacotherapeutic group
- ampoules 50 mg/ml 5 ml №5
- Сonditions of supply
- on prescription
Indications
- fatty liver degeneration (including diabetes mellitus);
- acute and chronic hepatitis;
- cirrhosis of the liver, necrosis of liver cells, hepatic coma and precoma, toxic liver damage;
- toxicosis of pregnancy;
- pre- and postoperative treatment, especially during operations in the area of the hepatobiliary zone;
- psoriasis;
- radiation syndrome.
Dosage regimen
Only clear solution should be used.
Do not inject the drug intramuscularly due to the possible occurrence of a local reaction.
The drug is injected slowly intravenously 5-10 ml (1-2 ampoules) per day, in severe cases - fr om 10 to 20 ml (2-4 ampoules) per day. It is allowed to inject 10 ml (2 ampoules) of the drug at a time.
To dilute the drug, it is recommended to use the patient's own blood in a 1:1 ratio.
The course of treatment is 10 days, followed by a switch to oral forms of phosphatidylcholine.
Treatment for psoriasis begins with oral phosphatidylcholine for 2 weeks. After that, 10 intravenous injections of 5 ml (1 ampoule) are recommended with the simultaneous appointment of PUVA therapy. After the end of the course of injections, oral forms of phosphatidylcholine are resumed.
In cases wh ere it is impossible to use the patient's own blood to dilute the drug, solutions free of electrolytes should be used - 5% or 10% glucose solution, 5% xylitol solution in a 1: 1 ratio.
